Dr. Mike Taussig
Position: Editor in Chief, New Biotechnology.
Mike Taussig graduated from Trinity College, Cambridge with a BA in Biochemistry and Ph.D in Immunology. After post-doc periods at the Weizmann Institute and the Basel Institute for Immunology, he joined the Babraham Institute in Cambridge where he is head of the Technology Research Group. Mike Taussig is currently head of the Technology Research Group at the Babraham Institute, Cambridge, UK. His research experience and interests include structure and genetics of antibodies, protein display libraries and selection, protein array design, cell free protein expression systems and X-ray crystallography. He is a co-inventor of ribosome display technology for selection of binding proteins, and protein array methods, where he has developed systems for producing protein arrays in situ from DNA. He is a board member of the European Federation of Biotechnology and chariman of the EFB section on Applied Functional Genomics. He is the coordinator of ProteomeBinders, an EU FP6 research infrastructure action aiming to establish a European resource of affinity binding reagents for detection of the human proteome. He has implemented and chaired two functional genomics programmes for the European Science Foundation, firstly Integrated Approaches to Functional Genomics (2000-2005) and currently Frontiers of Functional Genomics (2006-2011), which receives funding from research councils in 17 European countries. Thus he brings expertise both in research activity areas related to binding molecules, as well as in project management at the European level. He is a Fellow of Selwyn College, Cambridge, where he teaches General Pathology.
Designed by Prestigia OnlineCreated by the EFB TeamCopyright © 2017 European Federation of Biotechnology
28 March, 2017